Gagnon Securities’s Redhill Biopharma RDHL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,641
| Closed | -$43K | – | 103 |
|
|
2024
Q2 | $43K | Sell |
4,641
-93
| -2% | -$862 | 0.01% | 96 |
|
|
2024
Q1 | $62.7K | Buy |
4,734
+1,150
| +32% | +$15.2K | 0.01% | 94 |
|
|
2023
Q4 | $131K | Buy |
3,584
+1,665
| +87% | +$60.8K | 0.03% | 96 |
|
|
2023
Q3 | $24.5K | Buy |
+1,919
| New | +$24.5K | 0.01% | 96 |
|
|
2023
Q1 | – | Sell |
-332
| Closed | -$46.6K | – | 114 |
|
|
2022
Q4 | $46.6K | Sell |
332
-54
| -14% | -$7.57K | 0.01% | 103 |
|
|
2022
Q3 | $194K | Buy |
386
+11
| +3% | +$5.53K | 0.04% | 91 |
|
|
2022
Q2 | $327K | Buy |
375
+8
| +2% | +$6.98K | 0.07% | 82 |
|
|
2022
Q1 | $926K | Buy |
367
+49
| +15% | +$124K | 0.15% | 58 |
|
|
2021
Q4 | $821K | Sell |
318
-74
| -19% | -$191K | 0.12% | 58 |
|
|
2021
Q3 | $1.8M | Buy |
392
+49
| +14% | +$225K | 0.27% | 46 |
|
|
2021
Q2 | $2.36M | Buy |
343
+11
| +3% | +$75.6K | 0.33% | 44 |
|
|
2021
Q1 | $2.43M | Buy |
332
+51
| +18% | +$373K | 0.37% | 45 |
|
|
2020
Q4 | $2.27M | Buy |
281
+43
| +18% | +$348K | 0.36% | 45 |
|
|
2020
Q3 | $2.43M | Buy |
238
+28
| +13% | +$286K | 0.52% | 38 |
|
|
2020
Q2 | $1.41M | Buy |
210
+111
| +112% | +$744K | 0.34% | 43 |
|
|
2020
Q1 | $449K | Sell |
99
-14
| -12% | -$63.5K | 0.15% | 50 |
|
|
2019
Q4 | $683K | Buy |
+113
| New | +$683K | 0.15% | 56 |
|